Wave Life Sciences (WVE) Total Non-Current Liabilities (2014 - 2026)

Wave Life Sciences' Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $22.0 million for Q1 2026.

• Quarterly Total Non-Current Liabilities rose 3.21% year-over-year to $22.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.0 million (up 3.21% YoY) and the FY2025 annual result came in at $17.2 million, down 27.92% from the prior year.
• Total Non-Current Liabilities was $22.0 million for Q1 2026 at Wave Life Sciences, up from $17.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $161.5 million in Q1 2023 and bottomed at $17.2 million in Q4 2025.
• A 5-year average of $66.9 million and a median of $38.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 59.86% — and 2024, when it plunged 77.63%.
• Wave Life Sciences' Total Non-Current Liabilities stood at $112.1 million in 2022, then slumped by 63.42% to $41.0 million in 2023, then sank by 41.8% to $23.9 million in 2024, then fell by 27.92% to $17.2 million in 2025, then grew by 27.79% to $22.0 million in 2026.
• Business Quant data shows WVE's Total Non-Current Liabilities at $22.0 million in Q1 2026, $17.2 million in Q4 2025, and $23.1 million in Q3 2025.